Precision Medicine: Progress and Promise

As genomic technologies move from lab to clinic, how can business and government bridge the gap between availability and access? Dimensions to be addressed: - Health system infrastructure - Data on clinical and cost effectiveness - Lagging insurance models This session was developed in partnership with Scientific American. Simultaneous interpretation in English and Mandarin...